Clinical Trials Sponsored by Brian Badman

Total 1458 results

Brian Kenney

Withdrawn

Identifiable Factors That May Lead to Postoperative Nausea and Vomiting After Simple Laparoscopic Appendectomy

Acute Appendicitis

United States
Brian Burke, MPH

Unknown

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion

United States
Brian Lally

Completed

Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain

Brain and Central Nervous System Tumors

United States
Phillip Brian Smith

Withdrawn

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

Sepsis

United States
Phillip Brian Smith

Completed

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio) (Staph)

Systemic Infection

United States
Brian Wallace Gray

Completed

Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children

Laparoscopic Cholecystectomy

United States
Brian Callaghan

Completed

Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects

Obesity | Metabolic Syndrome | Neuropathy

United States
Nancy Bauman

Terminated

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Hemangioma of Infancy

United States
LUCINDA BATEMAN, MD
Endourage, LLC

Not yet recruiting

Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID

Post-acute COVID-19 Syndrome

United States
Dasman Diabetes Institute

Recruiting

Resistance Exercise and Cognition in People With Type 1 Diabetes

type1diabetes

Kuwait
Dasman Diabetes Institute

Recruiting

Krill Oil and Muscle Weakness in Type 2 Diabetes (KRIMD)

Diabetes Mellitus, Type 2

Kuwait
Dasman Diabetes Institute

Recruiting

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

Diabetes Mellitus, Type 2

Kuwait
Dasman Diabetes Institute

Completed

Obesity Treatment to Improve Diabetes (OTID)

Type 1 Diabetes

Kuwait
University of Ibadan

Completed

Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease (PECKO-D)

Parkinson Disease

Nigeria
Kadmon Corporation, LLC

Completed

Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy

Psoriasis Vulgaris

United States
Kadmon Corporation, LLC

Terminated

Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

HER-2 Positive Breast Cancer | Metastatic Malignant Neoplasm to Brain

United States
Kadmon Corporation, LLC

Completed

A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris

Psoriasis Vulgaris

United States
Kadmon Corporation, LLC

Completed

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Chronic Plaque Psoriasis

United States
Kadmon Corporation, LLC

Completed

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Glioblastoma | Brain Tumor | Recurrent Glioblastoma

United States
University of Ibadan

Completed

Effect of Standardized Hibiscus Sabdariffa Tea in Seemingly Healthy Human Volunteers

Healthy Human Volunteers

Nigeria
University of Ibadan

Completed

Impact of Pharmacists' Training on Oral Anticoagulant Counseling

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

Nigeria
Dasman Diabetes Institute

Unknown

Time-Restricted Feeding on Glucose Homeostasis and Quality of Life

Diabetes Mellitus, Type 2 | Time Restricted Feeding

Kuwait
Dasman Diabetes Institute

Recruiting

Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes (α-MSH & T2DM)

Type 2 Diabetes Mellitus

Kuwait
Dasman Diabetes Institute

Recruiting

Postprandial Glucose Response Using Mass-Market No-Added-Sugar Ice Cream

Type 2 Diabetes

Kuwait
Dasman Diabetes Institute

Recruiting

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program (KADEM)

PreDiabetes | NAFLD - Nonalcoholic Fatty Liver Disease | Diabetes Mellitus Type 2, Diabetes Mellitus Type 1

Kuwait
University of Ibadan

Recruiting

Management of Acute Uncomplicated UTIs in Adults by Community Pharmacists ([UTI])

Urinary Tract Infections | Urinary Tract Infection Lower Acute

Nigeria
W.J. Pasman

Completed

Appetite Suppression Trial With Polydextrose

Body Weight | Non-restrained Eaters

Netherlands
Kadmon Corporation, LLC

Completed

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

Carcinoma, Non-Small-Cell Lung

United States
Kadmon Corporation, LLC

Completed

Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

Non-small-cell Lung Cancer

United States
Kadmon Corporation, LLC

Completed

Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors

Cancer

United States
Kadmon Corporation, LLC

Terminated

KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy

Carcinoma, Non-Small-Cell Lung

United States
Dasman Diabetes Institute

Completed

"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)" (NODAT-ES)

Diabetes Mellitus | New Onset Diabetes After Transplant

Kuwait
University of Ibadan

Unknown

The Nigerian Surgical Outcomes Study. This Study is Aimed at Observing for Complications Within 30 Days After Surgery (NiSOS)

Postoperative Complications

Nigeria
University of Ibadan

Completed

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

HIV | Malaria | Pregnant

Nigeria
Banyan Biomarkers, Inc

Completed

Biomarkers of Mild and Moderate Traumatic Brain Injury

Brain Injuries, Traumatic

United States, Hungary
Banyan Biomarkers, Inc

Completed

Brain Injury Biomarkers in the General Population

Brain Injuries, Traumatic

United States
Banyan Biomarkers, Inc

Completed

A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes (GATOR)

Traumatic Brain Injury | Sports Injury | Sports Concussion

United States
Kadmon Corporation, LLC

Withdrawn

Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep C (REACHSVR)

Hepatitis C
University of Ibadan

Unknown

Stroke Inpatients Rehabilitation Reinforcement of Activity

Stroke

Nigeria
Banyan Biomarkers, Inc

Terminated

Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI

Brain Injuries, Traumatic

United States
Kadmon Corporation, LLC

Terminated

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin (ENHANCE)

Hepatitis C

United States
Bateman Horne Center

Recruiting

Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 (PASC)

Long COVID | PASC Post Acute Sequelae of COVID 19

United States
University of Ibadan

Not yet recruiting

Protocol for a Feasibility Cluster Randomised Controlled Trial of a Home-based Depression Care for Older People Delivered by Lay Providers in Nigeria (INDIGO)

Depression in Old Age
University of Ibadan

Not yet recruiting

Evaluation of Improved Outcomes Among Ambulatory Diabetes and/or Hypertensive Patients - an Intervention Study (CPCLINT) (CPCLINT)

Hypertension | Type 2 Diabetes Mellitus

Nigeria
Dasman Diabetes Institute

Recruiting

Timing of Resistance Exercise in Type 1 Diabetes (T-REX)

Type 1 Diabetes

Kuwait
University of Ibadan

Completed

Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Intervention Study

Nigeria
Kadmon Corporation, LLC

Completed

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Kadmon Corporation, LLC

Terminated

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States
Kadmon Corporation, LLC

Completed

Study of XL647 Administered Orally Daily to Patients With Solid Tumors

Cancer

United States
Kadmon Corporation, LLC

Completed

A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Polycystic Kidney, Autosomal Recessive

United States

3

Subscribe